Tag: Mylan
Politics and Greed: Who Benefited from the EpiPen Price Gouging Scandal?
"To get into something you don’t understand and your daughter being in this type of industry – it was best I stayed away."
Court Documents Show Mylan CEO Heather Bresch Played Integral Role in...
Bresch pressured counterpart at Pfizer to drop competing product.
Pfizer Proposes $345 Million Settlement Over EpiPen Price Gouging
Pfizer and subsidiaries deny any wrongdoing in settlement.
Sanofi Presses Court Battle with Mylan in Appeal of EpiPen Antitrust...
With billions at stake, Sanofi ups the ante with Mylan in their EpiPen suit.
Exec Who Told the Food Allergy Community to F— Themselves Received...
Robert Coury is no stranger to huge bonuses despite public outcry.
Mylan Loses Bid to Dismiss Class Action EpiPen Antitrust Lawsuit
Judge denies motion allowing lawsuit to continue.
How to Participate or Opt-Out of the Pending EpiPen Class-Action Lawsuit
Know your options and take action if necessary.
Parents Who Have Lost a Child to Anaphylaxis Speak Out in...
BSACI and ITN have released a program entitled "Allergy and Clinical Immunology – Attention Needed!" to raise awareness and educate.
FDA Warns of Possible Malfunctions for EpiPen, EpiPen Jr, and Mylan’s...
Devices may potentially have delayed injection or be prevented from properly injecting.
Ruling Allows Millions to Join Lawsuit in EpiPen Racketeering Case
US District Judge Daniel Crabtree ruled numerous lawsuits against the marketer and manufacturer of EpiPen may proceed as a nationwide class-action under a federal racketeering statute.
